Research Calls
- Upgrades:
- Nordex (NRDXF) upgraded to Buy from Neutral at Citigroup
- Okta (OKTA) upgraded to Neutral from Sell at Guggenheim; tgt lowered to $65
- Salesforce (CRM) upgraded to Neutral from Sell at Guggenheim; tgt $150
- Downgrades:
- Air Liquide (AIQUY) downgraded to Neutral from Conviction Buy at Goldman
- Arkema S.A. (ARKAY) downgraded to Neutral from Buy at Goldman
- Azure Power (AZRE) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt lowered to $5
- Dow (DOW) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $47
- Givaudan SA (GVDNY) downgraded to Sell from Neutral at Goldman
- Henkel AG (HENKY) downgraded to Sell from Neutral at Goldman
- LyondellBasell (LYB) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $80
- NVIDIA (NVDA) downgraded to Neutral from Outperform at Daiwa Securities; tgt lowered to $133
- Tilly's (TLYS) downgraded to Neutral from Buy at Seaport Research Partners
- Others:
- CrowdStrike (CRWD) initiated with a Neutral at Atlantic Equities; tgt $200
- Fortinet (FTNT) initiated with an Overweight at Atlantic Equities; tgt $76
- Palo Alto Networks (PANW) initiated with a Neutral at Atlantic Equities; tgt $495
- PROCEPT BioRobotics (PRCT) initiated with an Overweight at Wells Fargo; tgt $49
- Relay Therapeutics (RLAY) initiated with a Buy at Stifel; tgt $40